Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free CNSL Stock Alerts

Cambridge Nutritional Sciences (CNSL) Competitors

GBX 1.76 -0.14 (-7.47%)
As of 08/21/2026 11:37 AM Eastern
Compare

CNSL vs. IHC, RUA, AVO, ODX, and MHC

Should you buy Cambridge Nutritional Sciences stock or one of its competitors? Cambridge Nutritional Sciences's main competitors and comparable companies include Inspiration Healthcare Group (IHC), RUA Life Sciences (RUA), Advanced Oncotherapy (AVO), Omega Diagnostics Group (ODX), and MyHealthChecked (MHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does Cambridge Nutritional Sciences compare to Inspiration Healthcare Group?

Inspiration Healthcare Group (LON:IHC) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

7.4% of Inspiration Healthcare Group shares are held by institutional investors. Comparatively, 1.6% of Cambridge Nutritional Sciences shares are held by institutional investors. 6.1% of Inspiration Healthcare Group shares are held by company insiders. Comparatively, 7.8% of Cambridge Nutritional Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cambridge Nutritional Sciences has lower revenue, but higher earnings than Inspiration Healthcare Group. Inspiration Healthcare Group is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspiration Healthcare Group£47.55M0.36-£12.20M-£1.16N/A
Cambridge Nutritional Sciences£8.06M0.52-£3.03M£0.602.93

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Inspiration Healthcare Group's net margin of -2.19%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Inspiration Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspiration Healthcare Group-2.19% -6.49% -3.47%
Cambridge Nutritional Sciences 16.94%12.15%-2.36%

Inspiration Healthcare Group has a beta of 0.857, indicating that its share price is 14% less volatile than the broader market. Comparatively, Cambridge Nutritional Sciences has a beta of 1.93, indicating that its share price is 93% more volatile than the broader market.

In the previous week, Inspiration Healthcare Group's average media sentiment score of 0.00 equaled Cambridge Nutritional Sciences'average media sentiment score.

Company Overall Sentiment
Inspiration Healthcare Group Neutral
Cambridge Nutritional Sciences Neutral

Summary

Cambridge Nutritional Sciences beats Inspiration Healthcare Group on 9 of the 11 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to RUA Life Sciences?

RUA Life Sciences (LON:RUA) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations, valuation and media sentiment.

In the previous week, RUA Life Sciences' average media sentiment score of 0.00 equaled Cambridge Nutritional Sciences'average media sentiment score.

Company Overall Sentiment
RUA Life Sciences Neutral
Cambridge Nutritional Sciences Neutral

RUA Life Sciences has higher earnings, but lower revenue than Cambridge Nutritional Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RUA Life Sciences£4.11M3.93-£2.66MN/AN/A
Cambridge Nutritional Sciences£8.06M0.52-£3.03M£0.602.93

Cambridge Nutritional Sciences has a net margin of 16.94% compared to RUA Life Sciences' net margin of -3.26%. Cambridge Nutritional Sciences' return on equity of 12.15% beat RUA Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
RUA Life Sciences-3.26% -2.03% -17.50%
Cambridge Nutritional Sciences 16.94%12.15%-2.36%

RUA Life Sciences has a beta of 0.948, meaning that its stock price is 5% less volatile than the broader market. Comparatively, Cambridge Nutritional Sciences has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

0.1% of RUA Life Sciences shares are owned by institutional investors. Comparatively, 1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. 7.3% of RUA Life Sciences shares are owned by insiders. Comparatively, 7.8% of Cambridge Nutritional Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Cambridge Nutritional Sciences beats RUA Life Sciences on 8 of the 10 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Advanced Oncotherapy?

Cambridge Nutritional Sciences (LON:CNSL) and Advanced Oncotherapy (LON:AVO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Advanced Oncotherapy's net margin of 0.00%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Advanced Oncotherapy's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Advanced Oncotherapy N/A -67.34%-11.73%

1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. Comparatively, 17.8% of Advanced Oncotherapy shares are owned by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are owned by insiders. Comparatively, 47.5% of Advanced Oncotherapy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Cambridge Nutritional Sciences has higher revenue and earnings than Advanced Oncotherapy. Advanced Oncotherapy is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.52-£3.03M£0.602.93
Advanced OncotherapyN/AN/A-£32.60M-£0.07N/A

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Advanced Oncotherapy'saverage media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Advanced Oncotherapy Neutral

Cambridge Nutritional Sciences has a beta of 1.93, indicating that its share price is 93% more volatile than the broader market. Comparatively, Advanced Oncotherapy has a beta of 0.06, indicating that its share price is 94% less volatile than the broader market.

Summary

Cambridge Nutritional Sciences beats Advanced Oncotherapy on 8 of the 10 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Omega Diagnostics Group?

Omega Diagnostics Group (LON:ODX) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Omega Diagnostics Group's net margin of -51.15%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Omega Diagnostics Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Omega Diagnostics Group-51.15% -29.14% -10.53%
Cambridge Nutritional Sciences 16.94%12.15%-2.36%

In the previous week, Omega Diagnostics Group's average media sentiment score of 0.00 equaled Cambridge Nutritional Sciences'average media sentiment score.

Company Overall Sentiment
Omega Diagnostics Group Neutral
Cambridge Nutritional Sciences Neutral

29.8% of Omega Diagnostics Group shares are owned by institutional investors. Comparatively, 1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. 50.6% of Omega Diagnostics Group shares are owned by insiders. Comparatively, 7.8% of Cambridge Nutritional Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Omega Diagnostics Group has a beta of 3.85, meaning that its stock price is 285% more volatile than the broader market. Comparatively, Cambridge Nutritional Sciences has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

Cambridge Nutritional Sciences has higher revenue and earnings than Omega Diagnostics Group. Omega Diagnostics Group is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omega Diagnostics Group£7.55M0.00-£3.17M-£0.01N/A
Cambridge Nutritional Sciences£8.06M0.52-£3.03M£0.602.93

Summary

Cambridge Nutritional Sciences beats Omega Diagnostics Group on 7 of the 10 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to MyHealthChecked?

MyHealthChecked (LON:MHC) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

MyHealthChecked has higher earnings, but lower revenue than Cambridge Nutritional Sciences. MyHealthChecked is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MyHealthChecked£3.22M1.48-£1.04M-£3.76N/A
Cambridge Nutritional Sciences£8.06M0.52-£3.03M£0.602.93

MyHealthChecked has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market. Comparatively, Cambridge Nutritional Sciences has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

In the previous week, MyHealthChecked had 1 more articles in the media than Cambridge Nutritional Sciences. MarketBeat recorded 1 mentions for MyHealthChecked and 0 mentions for Cambridge Nutritional Sciences. MyHealthChecked's average media sentiment score of 0.75 beat Cambridge Nutritional Sciences' score of 0.00 indicating that MyHealthChecked is being referred to more favorably in the media.

Company Overall Sentiment
MyHealthChecked Positive
Cambridge Nutritional Sciences Neutral

Cambridge Nutritional Sciences has a net margin of 16.94% compared to MyHealthChecked's net margin of -49.51%. Cambridge Nutritional Sciences' return on equity of 12.15% beat MyHealthChecked's return on equity.

Company Net Margins Return on Equity Return on Assets
MyHealthChecked-49.51% -22.78% -8.18%
Cambridge Nutritional Sciences 16.94%12.15%-2.36%

0.7% of MyHealthChecked shares are owned by institutional investors. Comparatively, 1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. 9.3% of MyHealthChecked shares are owned by insiders. Comparatively, 7.8% of Cambridge Nutritional Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Cambridge Nutritional Sciences beats MyHealthChecked on 8 of the 13 factors compared between the two stocks.

Get Cambridge Nutritional Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNSL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNSL vs. The Competition

Export
MetricCambridge Nutritional SciencesHealthcare Equipment & Supplies IndustryHealthcare SectorLON Exchange
Market Cap£4.52M£6.02B£7.37B£2.54B
Dividend YieldN/A1.75%2.53%6.17%
P/E Ratio2.9326.67272.60367.57
Price / Sales0.5245.38618.9683,481.74
Price / CashN/A33.2478.6227.89
Price / Book0.446.2313.057.19
Net Income-£3.03M£150.07M£3.47B£5.89B
7 Day Performance-4.97%0.69%2.09%0.30%
1 Month Performance6.16%8.91%6.64%3.31%
1 Year Performance-43.29%8.07%25.02%22.13%

Cambridge Nutritional Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNSL
Cambridge Nutritional Sciences
N/AGBX 1.76
-7.5%		N/A-43.3%£4.52M£8.06M2.933,200
IHC
Inspiration Healthcare Group
N/AGBX 18.37
-0.7%		N/A-18.1%£16.47M£47.55MN/A224
RUA
RUA Life Sciences
N/AGBX 25.15
-5.1%		N/A+129.3%£15.61M£4.11MN/A48
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/AN/A3,900
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55MN/A91

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:CNSL) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel